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Various biological activities of alpha-lipoic acid (LA) have recently been reported. In our laboratory two four-
carbon products of LA biodegradation had been synthesized: tetranor-dihydrolipoic acid (tetranor-DHLA) and 
2,4-bismethylthiobutanoic acid (BMTBA). In subsequent experiments their biological properties were studied 
in order to assess if LA metabolites might exhibit biological activity in a living organism and show lower/
higher toxicity than the parental compound. In particular, the present study investigated antiproliferative 
activity of LA and its biodegradation derivatives, DHLA and BMTBA, using an in vitro cell model of murine 
fi broblast cell line 3T3-L1. Human fi broblasts and hepatoma cells were employed to compare the effects. MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) viability assay was used to measure adequate 
metabolic activity of cells incubated for 24 h with the addition of the tested compounds, in order to assess the 
structure-activity relationship. The strongest cytotoxic effect in the 3T3-L1 cell culture was observed after 
incubation of cells with tetranor-DHLA, the weakest effect was found for BMTBA. As regards LA and its 
derivatives tested in human fi broblasts, the most toxic compound was BMTBA, while LA was least toxic. The 
most toxic compound to hepatoma cells Hep G2 was tetranor-DHLA. 
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INTRODUCTION
Alpha-lipoic acid (LA) is a natural dithiol com-
pound which exhibits very strong antioxidant 
activity (BILSKA and WŁODEK, 2002; 2005; DUDEK 
et al., 2008). Numerous recent studies have con-
fi rmed the benefi cial properties of this compound 
in mammals, e.g. the regulation of the infl amma-
tory response of an organism (DUDEK et al., 2013; 
ZYGMUNT et al., 2013). Several pharmacological 
applications of LA were proposed, especially in 
the treatment of diabetic neuropathy (GORĄCA et 
al., 2011), neurodegenerative diseases (GORĄCA 
et al., 2011), cardiovascular diseases (DUDEK 
et al., 2014), intoxications (ICIEK et al., 2011; 
SOKOŁOWSKA et al., 2013; 2014) and many others. 
Also the reduced form of LA, dihydrolipoic acid 
(DHLA), shows very strong reducing properties 
(MOINI et al., 2002), however DHLA was report-
ed to be more toxic than LA (RTECS), therefore 
currently LA is being tested for use in medical 
therapies.
The estimation of drug toxicity is an impor-
tant step during the discovery process. The main 
problems, which one should take into consider-
ation, are unpredictable effects of chemicals on 
mammalian cells and, on the other hand, species 
and tissue specifi city of drug action.  The strategy 
of ADME/Tox studies also includes the estima-
tion of the toxicity of drug biodegradation prod-
ucts. Therefore the present study was performed 
to elucidate the differences in the cytotoxicity of 
LA, 2,4-bismethylthiobutanoic acid (BMTBA), 
which is one of the LA biotransformation pro-
ducts (SCHUPKE et al., 2001; TEICHERT et al., 2003; 
KWIECIEŃ et al., 2013) and tetranor-dihydrolipoic 
acid (tetranor-DHLA), a DHLA analogue. The 
process of synthesis of the compounds was de-
scribed by KWIECIEŃ et al. (2013). Biological ac-
tivities of the newly synthesized compounds, 
such as their anti-infl ammatory properties, have 
recently been intensively studied (KWIECIEŃ et 
al., 2013). Figure 1 shows the structures of the 
tested compounds.
As regards drug design, the testing process 
usually involves the characterization of com-
pounds in cell-based in vitro assays. This step 
enables screening for the prospective drug fea-
tures, such as low cytotoxicity and/or specifi c ac-
tivity towards tumor cells. The MTT (3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay is a widely used, standard method 
for measuring inhibition of cell proliferation in 
the process of optimizing new anticancer drugs. 
Since cytotoxicity and effect on the proliferation 
of cancer cells shown by the tested drugs are one 
of the most important parameters in cancer drug 
discovery, we also aimed to fi nd out if the tested 
compounds exhibited antitumor potency.
MATERIALS AND METHODS
Chemicals
Resistivity, MΩ•cm at 25°C, deionized wa-
ter (esistivity, MΩ•cm at 25°C) was obtained 
from Milli-Ro and Q water purifi cation system, 
(Merck-Millipore, USA), ethanol was from 
Merck. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) was purchased 
from Sigma (Germany). Trypan Blue reagent 
was from Invitrogen (USA). Media and sera 
were from ATCC (USA), antibiotic mixture and 
trypsin – 0.05% EDTA solution were from Gibco 
(USA). Sterile and non-toxic plates, fl asks, tips, 
centrifuge tubes were from Sarstedt (Germany).
Cell culture conditions and  MTT assay
Murine embryo fi broblasts (ATCC designation: 
3T3-L1, CL-173) were kept in Dulbecco’s Modi-
fi ed Eagle’s Medium (DMEM). Human hepato-
cellular carcinoma cells (ATCC designation: Hep 
G2, HB-8065) and human skin fi broblasts (ATCC 
designation: BJ, CCL-2522) were cultured in 
Eagle’s Minimum Essential Medium (EMEM). 
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Fig. 1. Chemical structures of LA biodegradation products.
A. – 2,4-bismethylthiobutanoic acid (BMTBA), 
B. – tetranordihydrolipoic acid (tetranor-DHLA)
A. B.
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The media were supplemented with 10% fetal 
bovine serum and with 1% antibiotic solution 
(100 IU/ml penicillin, 0.1 mg/ml streptomycin). 
The cells were subcultivated  twice a week us-
ing trypsin – 0.05% EDTA solution. Cell viabil-
ity during the culture was assessed with Try-
pan Blue Exclusion Test (Trypan Blue solution 
in buffered PBS without Ca++ Mg++, pH 7.4) 
in an automatic cell counter (Countess, Invitro-
gen). The cells in the exponential growth phase 
were seeded into 96-well plate at a density of 
5×104 cells/well in 200 μl of medium. For MTT 
test incubations, the positive control (100% 
of growth) were the cells cultured in medium 
with an adequate amount of solvent, etha-
nol, the negative control was prepared with 20 
mM/l of hydrogen peroxide. Six concentrations 
of lipoic acid dissolved in ethanol as well as LA 
derivatives (from 10-3 M to 10-6 M) were tested, 
each in triplicate. After 24 hours of incubation 
with the compounds, the media were replaced 
with fresh media containing additionally MTT 
(5 mg/ml in PBS, pH 7.4). Then MTT formazan 
generated during incubation was dissolved and 
the absorbance was measured at 550 nm (ref-
erence wavelenght was 690 nm) using BMG 
Labtech´s Fluostar Optima microplate reader 
[Labtech GMBH, Germany] (PASKO et al., 2013; 
NUNES et al., 2014, TYSZKA-CZOCHARA et al., 2014). 
Data analysis 
The MTT data were tested by one-way ANOVA, 
followed by Duncan’s post hoc test. Statistical 
calculations were carried out using the commer-
cially available packages Statistica v.5.1 (Stat-
Soft, Ic., Tulsa, USA). EC80 values were calculat-
ed using Omega Data Analysis (Labtech GMBH, 
Germany). 
RESULTS
To assess the structure-activity relationship of 
LA and LA derivatives, the cytotoxic activities 
of LA, tetranor-DHLA and BMTBA were deter-
mined using the colorimetric MTT assay. In mu-
rine (3T3-L1) and human (FB) fi broblasts, the 
inhibitory potency of all the tested compounds 
was less pronounced than in human hepatoma 
cells (Tab. 1). 
Table 1. Effects of LA and LA derivatives on murine (3T3-
L1) human (FB) fi broblasts and on hepatoma (Hep G2) cells.
3T3 L1 
cell line
FB 
cell line
Hep G2 
cell line
LA 225 281 145 
tetranor-DHLA 212 245 142 
BMTBA 300 235 150 
Cytotoxicity was measured by MTT test and expressed as 
EC80 (concentrations of compounds [μM] at which 80% 
cells were viable after 24 h of incubation with the tested 
compound). One of three independent measurements was 
presented.
The strongest cytotoxic effect in the 3T3-
L1 cell culture was observed after incubation 
of the cells with tetranor-DHLA (the lowest 
EC80 value), the weakest effect was found for 
BMTBA. As regards LA and its derivatives tested 
in human fi broblasts, the most toxic compound 
was BMTBA, while LA was least toxic. The most 
toxic compound to hepatoma cells Hep G2 was 
tetranor-DHLA, but the differences between the 
tested compounds were not signifi cant.
DISCUSSION 
Since the differences in cytotoxic potency be-
tween LA and its derivatives had already been 
reported, it was of interest to asses if different 
LA metabolites exerted a similar or different ef-
fect on mammalian cells. For this purpose, the in 
vitro model of murine (3T3-L1) and human (FB) 
fi broblasts was established. The effect obtained 
in physiological cell lines was compared with the 
effect in tumor cells (Hep G2). The MTT viability 
assay showed adequate metabolic activity of cells 
incubated for 24 h with the addition of the tested 
compounds. 
In the case of intraperitoneal infusion of LA 
in mice, the toxicity was established at 160 mg/
kg b.w. and at 100 mg/kg b.w. after the exposure 
of animals to DHLA (RTECS, 2014). DHLA is a 
more potent cytotoxic agent than LA acid because 
of a different cytotoxic mechanism involved (YA-
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MASAKI et al., 2009).  In the present experiments 
using the in vitro model of mouse fi broblasts the 
same tendency was observed, since EC80 values 
were higher for LA as compared with tetranor-
DHLA (Tab. 1). As regards human physiological 
fi broblasts, the trend was also preserved, which 
may suggest that higher cytotoxicity of DHLA, 
compared with LA, is maintained through spe-
cies. Acute toxicity of BMTBA after one intra-
peritoneal infusion in mice was 588.57 mg/kg 
b.w., and 75.4 mg/kg b.w. for tetranor-DHLA 
(KWIECIEŃ et al., 2013). Accordingly, in our ex-
periments the cytotoxicity of tetranor-DHLA in 
the murine fi broblast cell line was, on average, 
30% greater compared with BMTBA. The data 
obtained for human physiological fi broblasts 
showed no signifi cant differences in the cytotox-
icity of tetranor-DHLA and BMTBA.  
Previous reports pointed out the ability of LA 
to exhibit antiproliferative activity towards tu-
mor cells and revealed that the anticancer me-
chanisms of LA and DHLA and its derivatives in-
volves cell cycle arrest and induction of apoptosis 
in tumor cells (CASCIARI et al., 2001, YAMASAKI et 
al., 2009). The present study supports these fi nd-
ings because EC80 values measured for the hepa-
toma cell line were almost two times lower for all 
the tested compounds than the values measured 
for physiological cells, for both the tested species.
Biological effectiveness of LA and its deriva-
tives and anticancer activity may be related to 
their ability to modify the oxidation-reduction 
status of exposed cells (HAN et al., 1997; CASCIARI 
et al., 2001). In our previous studies antioxidant 
activity of the tested compounds was determined 
in vitro using two independent methods: ferric re-
ducing/ antioxidant power assay (FRAP) and the 
infl uence on lipid peroxidation (determination of 
thiobarbituric acid-reactive substances, TBARS) 
(DUDEK et al., 2014). The performed experiments 
showed that LA and tetrano-DHLA had strong 
antioxidant properties. It corresponds with the 
present fi ndings and it can be speculated that 
the antiproliferative action of these compounds 
towards hepatoma cells may be attributed to spe-
cifi c regulation of oxidative stress in cancer cells. 
At the same time, BMTBA does not exhibit any 
signifi cant antioxidant potency, therefore pro-
bably additional mechanisms are involved in the 
antitumor performance of this compound. 
In conclusion, the results of the present study 
revealed differences in cytotoxicity of LA, tetrano-
DHLA and BMTBA, depending on the compound 
structure. The effect was species-related and the 
antiproliferative action of the tested drugs was 
explicit in the hepatoma cell line. LA is consi-
dered as a promising chemopreventive agent and 
we hope that the obtained data will contribute 
to successful design of new derivatives and to a 
better understanding of the role which particular 
compounds play in the living system.
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